Literature DB >> 4502569

Daunorubicin. Results in childhood leukaemia.

R N Matthews, J H Colebatch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4502569      PMCID: PMC1648077          DOI: 10.1136/adc.47.252.272

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  6 in total

1.  Rubidomycin. A new agent active in the treatment of acute lymphoblastic leukaemia.

Authors:  C Jacquillat; M Boiron; M Weil; J Tanzer; Y Najean; J Bernard
Journal:  Lancet       Date:  1966-07-02       Impact factor: 79.321

2.  Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia.

Authors:  C Tan; H Tasaka; K P Yu; M L Murphy; D A Karnofsky
Journal:  Cancer       Date:  1967-03       Impact factor: 6.860

3.  Daunomycin treatment in acute leukemia.

Authors:  J F Holland
Journal:  Pathol Biol       Date:  1967-10

4.  [Cardiac complications observed during treatment with rubidomycin].

Authors:  C Macrez; H Marneffe-Lebrequier; J Ripault; J P Clauvel; C Jacquillat; M Weil
Journal:  Pathol Biol       Date:  1967-10

5.  Preliminary experience with rubidomycin in the treatment of acute lymphoblastic leukaemia resistant to other antimetabolites.

Authors:  R M Hardisty; P M Norman
Journal:  Pathol Biol       Date:  1967-10

6.  [Trial of treatment of acute lymphoblastic and myeloblastic leukemias by a new antibiotic: rubidomycin (RP 13,057). Study of 61 cases].

Authors:  J Bernard; C Jacquillat; M Boiron; Y Najean; M Seligmann; J Tanzer; M Weil; P Lortholary
Journal:  Presse Med       Date:  1967-04-22       Impact factor: 1.228

  6 in total
  2 in total

1.  Treatment of acute lymphoblastic leukaemia.

Authors:  L F Sinks
Journal:  Arch Dis Child       Date:  1972-10       Impact factor: 3.791

Review 2.  Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

Authors:  V B Pai; M C Nahata
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.